Bioaffinity Technologies Inc.
13F holders, Q1 2026 (March 31)14holders +5
6new positions
3sold out
$3.83avg. 13F price*
At the end of Q1 2026, 14 institutions reported holding Bioaffinity Technologies Inc. in their 13F filings, up 5 from Q4 2025. 6 opened new positions and 3 sold out. The largest holders were Vanguard Capital Management LLC ($213K), Geode Capital Management, LLC ($185K) and J. Safra Sarasin Holding AG ($164K).
- Company
- Bioaffinity Technologies Inc.
- CUSIP
- 09076W307
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $352K |
| Exits | 3 | $27K |
All 13F filers, Q4 2025 → Q1 2026: 109,485 shares bought and 32,319 shares sold, net +77,166 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Vanguard Capital Management LLC | 0.00% | — | 55,543 | $213K |
| Geode Capital Management, LLC | 0.00% | Add +58.7% | 48,293 | $185K |
| J. Safra Sarasin Holding AG | 0.00% | New | 42,600 | $164K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 31,071 | $119K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 24,413 | $94K |
| State Street Corp. | 0.00% | New | 14,386 | $55K |
| Northern Trust Corp. | 0.00% | No change | 12,725 | $49K |
| UBS Group AG | 0.00% | New | 9,214 | $35K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -47.2% | 2,063 | $8K |
| Ameritas Advisory Services, LLC | 0.00% | New | 1,000 | $4K |
| IFP Advisors, Inc | 0.00% | No change | 833 | $3K |
| Citigroup Inc. | 0.00% | Reduce -99.3% | 57 | $218 |
| Morgan Stanley | 0.00% | No change | 3 | $11 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $4 |
"% of holder's portfolio" is BIOAFFINITY TECHNOLOGIES INC's weight in each manager's 13F, not the share of Bioaffinity Technologies Inc. the manager owns.